Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

271

Participants

Timeline

Start Date

December 13, 2013

Primary Completion Date

February 21, 2018

Study Completion Date

February 21, 2018

Conditions

Internalizing Psychopathologies (IPs) Depression and Anxiety

Interventions

DRUG

SSRI

BEHAVIORAL

CBT

Trial Locations (1)

University of Illinois at Chicago, Chicago

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Illinois at Chicago

OTHER

NCT01903447 - Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment | Biotech Hunter | Biotech Hunter